Sector: MedicalOGXI (NASDAQ: OGXI)
Headlines
- OncoGenex Announces that a Randomized, Investigator-Sponsored Phase 2 Study Evaluating OGX-427 has Received Grant Funding
Jan 06, 2010 06:01 AM |
- Hot Stocks Of The Day: AA, AET, OGXI, WAG, TEX
Dec 21, 2009 02:56 PM | AA, AET, TEX, WAG
- Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva
Dec 21, 2009 08:15 AM | ISIS, TEVA
- Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications
Dec 21, 2009 08:08 AM |
- OncoGenex Pharmaceuticals to Host Investor Conference Call at 8:30 a.m. ET, December 21, 2009
Dec 20, 2009 08:13 PM |
- Pfizer and B.C. launch $9M collaboration to tackle cancer
Dec 03, 2009 01:16 PM | HUN, PFE
- OncoGenex Reports Third Quarter 2009 Financial Results
Nov 05, 2009 04:04 PM | ISIS
- OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
Nov 02, 2009 04:00 PM |
- OncoGenex (OGXI): Targeting Cancer Treatment
Oct 30, 2009 11:20 AM |
- Ryan Beedie est nommé Entrepreneur de l'année pour le Pacifique
Oct 09, 2009 10:46 AM | LGF, TGB, TKO
- Teva, OncoGenex sign drug development deal
Dec 21, 2009 12:52 PM | ISIS, TEVA
- OncoGenex Reports Second Quarter 2009 Financial Results
Aug 06, 2009 04:54 PM | ISIS
- OncoGenex Secures $9.5 Million in Registered Direct Offering
Jul 24, 2009 11:08 AM |
- OncoGenex to Raise $9.5 Million in Registered Direct Offering
Jul 21, 2009 11:56 AM |
- OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
Jul 20, 2009 04:55 PM | ISIS
- OncoGenex Reports First Quarter Financial Results
May 07, 2009 06:54 AM |
- OncoGenex Pharmaceuticals Named Life Sciences Company of the Year By LifeSciences British Columbia
Apr 09, 2009 06:55 PM |
- Northwest Stocks Outperform Other Regions
Oct 01, 2008 11:57 AM | AIG, BDAY, FNM, FRE, GYI, JPM
- OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX- 011
Aug 10, 2009 06:52 AM | ISIS
- OncoGenex Pharmaceuticals Announces Issuance of Key Patent for OGX-011
Aug 10, 2009 06:00 AM |
- BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Aug 06, 2009 06:53 AM | ARNA, AVII, AZN, BMR, CEPH, EPCT
- OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
Aug 03, 2009 06:00 AM |
- OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering
Jul 24, 2009 06:54 AM | ISIS
- OncoGenex Pharmaceuticals to Raise $9.5 Million Through Sale of Common Stock
Jul 20, 2009 03:55 PM |
- OncoGenex Pharmaceuticals Added to Russell Indexes
Jun 30, 2009 06:00 AM |
- OncoGenex Pharmaceuticals Files Shelf Registration Statement
Jun 26, 2009 04:02 PM |
- OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
Jun 24, 2009 06:01 AM |
- Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO
Jun 01, 2009 08:03 AM | ISIS
- Form 4 ONCOGENEX PHARMACEUTICAL For: Jan 28 Filed by: Cormack Scott Daniel (10K)
Jan 29, 2010 11:54 AM
- Form 4 ONCOGENEX PHARMACEUTICAL For: Dec 31 Filed by: JACOBS CINDY (10K)
Jan 04, 2010 02:57 PM
- Form 4 ONCOGENEX PHARMACEUTICAL For: Dec 31 Filed by: Cormack Scott Daniel (10K)
Jan 04, 2010 02:53 PM
- Form 4 ONCOGENEX PHARMACEUTICAL For: Dec 31 Filed by: Anderson Stephen Charles (10K)
Jan 04, 2010 02:48 PM
- Form 4 TAMER ANTHONY For: Jun 03 (10K)
Jun 05, 2009 06:33 PM
- Form 4 TAMER ANTHONY For: May 22 (10K)
May 28, 2009 12:33 PM
- Form 4 MNAYMNEH SAMI For: May 22 (10K)
May 27, 2009 08:28 PM
- Form 4 Brady Patrick Robert For: May 12 (10K)
May 13, 2009 07:26 PM
- Form 4 Clendeninn Neil James For: May 12 (10K)
May 13, 2009 07:19 PM
- Form 4 BURRIS MICHELLE For: May 12 (10K)
May 13, 2009 07:13 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
OGXI
|
Compare to S&P
|
| YTD |
-30.48 %
|
-27.29 %
|
| 4 Weeks |
-24.48 %
|
-18.90 %
|
| 12 Weeks |
-48.31 %
|
-46.99 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 51.22 %
|
|
EPS Growth in Last Year: -671.43 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
